Molecular regulation of arteriovenous endothelial cell specification

F1000Res. 2019 Jul 29:8:F1000 Faculty Rev-1208. doi: 10.12688/f1000research.16701.1. eCollection 2019.

Abstract

The systemic circulation depends upon a highly organized, hierarchal blood vascular network that requires the successful specification of arterial and venous endothelial cells during development. This process is driven by a cascade of signaling events (including Hedgehog, vascular endothelial growth factor (VEGF), Notch, connexin (Cx), transforming growth factor-beta (TGF- β), and COUP transcription factor 2 (COUP-TFII)) to influence endothelial cell cycle status and expression of arterial or venous genes and is further regulated by hemodynamic flow. Failure of endothelial cells to properly undergo arteriovenous specification may contribute to vascular malformation and dysfunction, such as in hereditary hemorrhagic telangiectasia (HHT) and capillary malformation-arteriovenous malformation (CM-AVM) where abnormal vessel structures, such as large shunts lacking clear arteriovenous identity and function, thereby compromising peripheral blood flow. This review provides an overview of recent findings in the field of arteriovenous specification and highlights key regulators of this process.

Keywords: artery; endothelial cell specification; vascular development; vein.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • COUP Transcription Factor II
  • Cell Cycle*
  • Endothelial Cells* / physiology
  • Humans
  • Signal Transduction*
  • Vascular Endothelial Growth Factor A
  • Veins

Substances

  • COUP Transcription Factor II
  • Vascular Endothelial Growth Factor A

Grants and funding

This work was supported by the National Institutes of Health (HL128064, HL096360, and EB017103) and CT Innovations (15-RMB-YALE-04 and 15-RMB-YALE-07).